Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Belgium Health Review.
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium
STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
CorVista Health Appoints Guido Neels and Dino Trevisani to Board of Directors
Veteran MedTech leader Guido Neels joins CorVista, leveraging his experience as EW Healthcare Partners Operating Partner and former Guidant COO. Company founder Dino Trevisani returns to CorVista, bringing decades of global technology expertise...
Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal Intervention Symposium
, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented “alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage” Ghent, Belgium – September 30, 2025 – Sequana Medical NV...
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has been included in a long-term reimbursement...
In Madrid and Melilla, NATO Parliamentarians Spotlight Shared Security Challenges on Europe’s Southern Flank
01 October 2025 Security on the Southern Flank is inseparable from that of the entire Alliance: challenges such as migration, terrorism and instability in NATO’s neighbourhood impact all Allies and demand collective responses. In a visit to Madrid...
Owner: NATO Parliamentary Assembly
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 26 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid...
Belgium, Luxembourg, Malta Recognize State of Palestine
(MENAFN) In a significant diplomatic shift, Belgium, Luxembourg, and Malta have officially recognized Palestine as a state during a summit held alongside the United Nations General Assembly in New York, further bolstering European Union support...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Press release: Sequana Medical announces H1 2025 results and provides business update
Sequana Medical announces H1 2025 results and provides business update alfapump® US commercialisation underway; Strengthened US reimbursement with CMS approval of NTAP “top-up” reimbursement; On track for at least 70 US commercial alfapump...
Active Pharmaceutical Ingredients (API) CDMO Market to Grow at a CAGR of 7.06% in the Forecast Period of 2025-2032
Active Pharmaceutical Ingredients CDMO Market was valued at USD 126.54 Bn. in 2024 and is projected to reach USD 218.4 Bn. WILMINGTON, DE, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- Active Pharmaceutical Ingredients CDMO Market was...
Canada, European Nations Call on Israel to Reopen Medical Corridor
(MENAFN) Canada, along with several European states, pressed Israel on Monday to reestablish the medical corridor linking Gaza with the occupied West Bank, including East Jerusalem, to ensure that patients can receive critical treatment. In a...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Belgium Voices Unwavering Support for EU Sanctions on Israel
(MENAFN) Belgian Prime Minister Bart De Wever announced his country’s unwavering support for any European Union sanctions against Israel, following the escalating conflict in Gaza. De Wever argued that these measures are crucial to exert pressure...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, Galapagos announced that its Board of Directors (the “Board”) had decided to...
At CPHI Frankfurt, TekniPlex Healthcare to Present Full Range of Barrier Blister Films, Customized Liquid Drug Delivery Solutions and Live Demonstrations of Latest Filling-Sealing Machine
Wayne, PA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will spotlight its extensive portfolio of barrier blister films at CPHI Frankfurt,...
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. Mont-Saint-Guibert, Belgium – September 15, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah, Inc. (collectively, “Nyxoah” or the...
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 15 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana...
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
WAYNE, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company...
Complementary and Alternative Medicine Market is the focus of a groundbreaking new report by Maximize Market Research
Complementary and Alternative Medicine revenue is expected to grow at a CAGR of 17.9% from 2025 to 2032, reaching nearly USD 504.52 Billion WILMINGTON, DE, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- Maximize Market Research recently...
Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
Tinlarebant has been granted Breakthrough Therapy, Fast Track, and Rare Pediatric Disease Designations in the U.S.; Orphan Drug Designation in the U.S., Europe, and Japan; and Pioneer Drug Designation in Japan for Stargardt disease Last subject...
Belgium Reveals Plans to Recognize State of Palestine
(MENAFN) Belgium will officially recognize Palestine as a state during the upcoming United Nations General Assembly in New York later this month, Foreign Minister Maxime Prevot revealed Monday. Announcing the move via the social media platform X,...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Press Release : Sequana Medical Announces New Share Capital Amount and New Number of Shares
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid...